CART-38 in Adult AML and MM Patients - 1

Study of CAR T-cell treatment in adults with AML or multiple myeloma

Age
99 years or below
Gender
All
Location
1

Brief description of study

See protocol section 2 See protocol section 2 See protocol section 4

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

The purpose of this research study is to learn about a CAR T-cell treatment in adults with acute myeloid leukemia (AML) or multiple myeloma.

Participants will receive a CAR T-cell treatment as part of the study.

Updated on 30 Jun 2025. Study ID: 679878443
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research